Literature DB >> 10197673

Randomized trial of intermittent antegrade warm blood versus cold crystalloid cardioplegia.

L M Jacquet1, P H Noirhomme, M J Van Dyck, G A El Khoury, A J Matta, M J Goenen, R A Dion.   

Abstract

BACKGROUND: We performed a prospective randomized trial to compare intermittent antegrade warm blood cardioplegia with intermittent antegrade and retrograde cold crystalloid cardioplegia.
METHODS: Two hundred consecutive patients scheduled for isolated coronary bypass surgical procedures were randomized into two groups: Group 1 (n = 92) received cold crystalloid cardioplegia with moderate systemic hypothermia, group 2 (n = 108) received intermittent antegrade warm blood cardioplegia with systemic normothermia. Preoperative, intraoperative, and postoperative data were prospectively collected.
RESULTS: For the same median number of distal anastomoses, cardiopulmonary bypass duration and total ischemic arrest duration (57.3 +/- 20.5 versus 75 +/- 22.1 minutes, p < 0.001) were shorter in group 2 than in group 1. Apart from a higher right atrial pressure in the cold cardioplegia group, no hemodynamic difference was observed. Aspartate aminotransferase, creatine kinase-MB fraction, and cardiac troponin I levels were significantly lower in group 2 than in group 1. Outcome variables were not significantly different.
CONCLUSIONS: Intermittent antegrade warm blood cardioplegia results in less myocardial cell damage than cold crystalloid cardioplegia, as assessed by the release of cardiac-specific markers. This beneficial effect has only marginal clinical consequences. Normothermic bypass has no deleterious effect on end-organ function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10197673     DOI: 10.1016/s0003-4975(98)01198-9

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

Review 1.  Is there a rationale for short cardioplegia re-dosing intervals?

Authors:  Yves D Durandy
Journal:  World J Cardiol       Date:  2015-10-26

Review 2.  Therapeutic hypothermia and prevention of acute kidney injury: a meta-analysis of randomized controlled trials.

Authors:  Paweena Susantitaphong; Mansour Alfayez; Abraham Cohen-Bucay; Ethan M Balk; Bertrand L Jaber
Journal:  Resuscitation       Date:  2011-10-06       Impact factor: 5.262

3.  Perfusionist strategies for blood conservation in pediatric cardiac surgery.

Authors:  Yves Durandy
Journal:  World J Cardiol       Date:  2010-02-26

4.  Cold crystalloid versus warm blood cardioplegia in patients undergoing aortic valve replacement.

Authors:  Paolo Nardi; Sara R Vacirca; Marco Russo; Dionisio F Colella; Carlo Bassano; Antonio Scafuri; Antonio Pellegrino; Gerry Melino; Giovanni Ruvolo
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

5.  Intravascular leiomyoma with heart extension.

Authors:  Marcia Maria Morales; Alexandre Anacleto; João Carlos Leal; Sergio Carvalho; Jerônimo Del'Arco
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

6.  Warm blood cardioplegia versus cold crystalloid cardioplegia for myocardial protection during coronary artery bypass grafting surgery.

Authors:  Paolo Nardi; Calogera Pisano; Fabio Bertoldo; Sara R Vacirca; Guglielmo Saitto; Antonino Costantino; Emanuele Bovio; Antonio Pellegrino; Giovanni Ruvolo
Journal:  Cell Death Discov       Date:  2018-02-14

7.  St. Thomas Modified Cardioplegia Effects on Myoblasts' Viability and Morphology.

Authors:  Rafał Nowicki; Katarzyna Bieżuńska-Kusiak; Julita Kulbacka; Anna Choromanska; Małgorzata Daczewska; Stanisław Potoczek; Maciej Rachwalik; Jolanta Saczko
Journal:  Medicina (Kaunas)       Date:  2022-02-13       Impact factor: 2.430

8.  Warm versus cold cardioplegia in cardiac surgery: A meta-analysis with trial sequential analysis.

Authors:  Thompson Ka Ming Kot; Jeffrey Shi Kai Chan; Saied Froghi; Dawnie Ho Hei Lau; Kara Morgan; Francesco Magni; Amer Harky
Journal:  JTCVS Open       Date:  2021-03-31

9.  Rationale for Implementation of Warm Cardiac Surgery in Pediatrics.

Authors:  Yves Durandy
Journal:  Front Pediatr       Date:  2016-05-06       Impact factor: 3.418

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.